BioSpace News Archive

Enlivex Therapeutics Ltd., a clinical-stage macrophage reprogramming immunotherapy company, announced that financial results for the second quarter ended June 30, 2021 were filed with the SEC on August 6, 2021 and provided a business update.

US Biologic today announces a partnership with BARDA DRIVe to develop oral influenza vaccines, increasing access to these life-saving technologies.

BioLife Solutions, Inc. (Nasdaq: BLFS) (“BioLife” or the “Company”), a leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma market, today announced that it has entered into a definitive agreement to acquire all remaining outstanding shares of privately held Sexton Biotechnologies, Inc.,

INOVIO (NASDAQ:INO), today announced that it has received regulatory allowance for two clinical trials investigating heterologous boosting with INO-4800, its DNA vaccine candidate for COVID-19, through partner and trial-sponsor Advaccine Biopharmaceuticals Suzhou Co.,

To address the ongoing demand for COVID-19 testing and to catalyze safe return of the workforce, Dalrada Corporation (OTCQB: DFCO, “Dalrada”) is excited to announce that its subsidiary, Dalrada Health, entered into a joint venture partnership with Vivera Pharmaceutical, Inc. (“Vivera”) to form Pala Diagnostics, LLC (“Pala Diagnostics”).

Cortexyme, Inc. today provided an update on expected clinical top-line data and reported second quarter 2021 financial results.

Sexton Biotechnologies today announced that it has entered into a definitive agreement whereby BioLife Solutions (NASDAQ: BLFS) will acquire all outstanding shares of the company in a deal worth a total value of $30 million.

H1, which provides the largest global healthcare platform that connects healthcare professionals, announced today that it has acquired Portland, Oregon based Carevoyance, which offers the best targeting, sales enablement, and physician segmentation platform to medical device sellers.

Thermo Fisher Scientific Inc. (NYSE: TMO) (" Thermo Fisher ") announced today that it intends to offer USD-denominated senior notes.

Oramed Pharmaceuticals Inc. announced today that Chief Commercial Officer Michael Rabinowitz will present a company overview at Canaccord Genuity’s 41st Annual Growth Conference, held virtually this year from August 10-12, 2021.